Individualised Care Vs. the Polypill Debate

For years, there’s been a growing conversation about whether everyone over a certain age should take preventive medication. The so-called ‘polypill’ approach proposes that all adults over 50 be prescribed a combination of low-dose statins, blood pressure medication, and other cardiovascular drugs as a one-size-fits-all strategy to prevent heart attacks and strokes.

While it sounds like a simple solution – linked with fewer heart attacks, deaths, and hospitalisations – medicine isn’t just about statistics, it’s about people. When it comes to long-term prevention, personalised, data-driven care is far more effective than blanket prescriptions.

The appeal of the polypill

The concept of the polypill, or fixed-dose combination (FDC) therapy, was born from good intentions. Cardiovascular disease remains the leading cause of death worldwide, and studies have shown that statins and blood pressure medications can significantly reduce risk when used appropriately. Combining these medications into a single daily pill could make prevention easier, more affordable, and more consistent.

One review found that polypills were associated with an 11 per cent lower risk of death from any cause and a 29 per cent lower risk of atherosclerosis cardiovascular disease events compared with people who did not take them.

However, as with many broad public health strategies, simplicity can come at a cost. While the polypill may reduce overall population risk, it overlooks the individual variation that determines who truly benefits, and who might not.

Why one size doesn’t fit all

Cardiovascular health is complex. It’s influenced not just by cholesterol and blood pressure, but also by inflammation, hormonal balance, metabolic function, genetics, and even environmental exposures. Two people of the same age can have completely different cardiovascular risk profiles. One may have mild hypertension and poor metabolic control, while the other has optimal blood sugar levels, strong vascular health, and no evidence of inflammation.

Prescribing the same medication to someone simply because they’ve passed a certain birthday fails to recognise this complexity. It risks over-treating some patients, introducing unnecessary side effects (one article mentions concerns about dizziness or falls from low blood pressure), and under-investigating others, whose root causes may lie outside traditional risk factors.

An individualised, functional medicine approach

Dr Grosser’s philosophy is simple – prevent disease by understanding the biological mechanisms behind it.

Instead of automatically prescribing medication, he begins with a comprehensive assessment that includes metabolic and hormonal testing, inflammation markers and advanced lipid profiling. TruAge biological age testing can inform how quickly a patient’s cardiovascular system is aging on a cellular level.

This approach often reveals hidden contributors to cardiovascular risk, such as insulin resistance, thyroid dysfunction, chronic stress, or nutrient deficiencies, that wouldn’t appear on a standard cholesterol test. Addressing these root causes early can significantly reduce disease risk without resorting to lifelong medication for every patient.

Choose a tailored treatment plan

If you’re approaching midlife and want to understand your true cardiovascular risk, Dr Grosser’s integrative assessment can provide a clear, individualised roadmap. Through advanced functional testing and personalised treatment planning, you’ll gain the insight to make informed choices about prevention, without unnecessary medication.

To find out more, book a consultation with Dr Konrad Grosser today.

/by

Intermittent Fasting and the Cognitive Benefits for Your Brain

We often think of intermittent fasting as a strategy for weight loss, but the benefits may go far deeper than the waistline. Emerging research suggests that fasting could also support brain function, memory, and long-term cognitive health.

This connection between fasting and brain health fits neatly into the broader picture of holistic wellness. After all, the brain and body are not separate systems; how we eat, sleep, and manage our energy, has a direct impact on how we think, focus, and remember.

Intermittent fasting and cognitive impact – the research

Intermittent fasting (IF) involves alternating periods of eating and fasting, with typically between 12 to 16 hours of fasting per day, though longer patterns are sometimes used under supervision. During fasting, insulin levels drop, cells begin to clear damaged material, and the body shifts into a mode known as metabolic switching, burning fat for energy rather than glucose.

Research is beginning to uncover how these processes support the brain. A systematic review carried out in 2024, showed that intermittent fasting may improve neuroplasticity. This is the brain’s ability to form new connections. It can also reduce inflammation and oxidative stress, two major contributors to neurodegenerative disease.

Another study carried out in 2022, found that intermittent fasting enhances mitochondrial efficiency, allowing neurons to function more effectively and resist damage over time.

How fasting supports brain function

The benefits of intermittent fasting can be traced back to several key biological mechanisms. When you fast, the body experiences a temporary stressor, enough to trigger repair processes without causing harm. This mild stress activates autophagy, clearing out old or damaged cells and replacing them with healthier ones.

This process is particularly important for neurons, which rely on clean, efficient energy pathways to function optimally. Fasting also stimulates the production of brain-derived neurotrophic factor (BDNF). BDNF supports the growth and survival of new neurons, enhances synaptic plasticity, and helps protect against cognitive decline.

Fasting also improves insulin sensitivity and stabilises blood sugar levels, factors closely linked to cognitive health. Chronically high insulin and glucose levels, often seen in insulin resistance and Type 2 diabetes, are known to impair memory and increase the risk of dementia. By resetting metabolic balance, fasting helps restore the brain’s ability to use energy efficiently, reducing the long-term risk of neurodegeneration.

How this links with functional medicine

From a functional medicine standpoint, intermittent fasting represents a powerful, low-cost intervention that supports the entire metabolic network, linking the gut, liver, cardiovascular system, and brain. But fasting should be integrated into a broader treatment plan so that patients achieve better glucose regulation, hormone balance, and mitochondrial health, all of which support sharper thinking and emotional stability.

However, fasting isn’t suitable for everyone. For those with adrenal fatigue, thyroid dysfunction, or certain cardiovascular conditions, fasting should be carefully tailored. After a personalised assessment, functional testing can be used to evaluate nutrient status, hormone balance, and mitochondrial function before beginning a fasting plan.

Is fasting right for you, and how is it measured?

One of the most exciting developments in this field is the ability to measure how fasting affects biological age. Through TruAge testing, Dr Grosser can assess how lifestyle interventions, like fasting, are influencing your rate of cellular aging.

Many patients who adopt structured fasting protocols alongside balanced nutrition and exercise see measurable improvements.

The research is increasingly clear that fasting may not only extend your metabolic health span, but also preserve your cognitive function well into later life.

To explore whether intermittent fasting and functional testing could benefit your cognitive and metabolic health, book a consultation with Dr Konrad Grosser. A personalised, evidence-based plan could help you sharpen your focus today and protect your brain for the future.

 

/by

Early-Onset Type 2 Diabetes on the Rise

Type 2 diabetes has long been viewed as a condition that develops slowly in midlife, often after years of poor diet, low activity, and gradual weight gain. But that narrative is changing, fast.

According to recent figures, diagnoses of Type 2 diabetes in people under 40 have surged by 40% in just a few years. That’s not a minor shift; it’s a warning sign.

This growing trend highlights the need for early metabolic screening, better lifestyle interventions, and more sophisticated testing to identify problems long before they evolve into lifelong disease.

Standard health screenings are too late

The rise in early-onset diabetes can’t be explained by genetics alone. It’s a condition driven by environmental factors, such as ultra-processed diets, sedentary behaviour, disrupted sleep, chronic stress, and exposure to endocrine-disrupting chemicals. Many young adults today are experiencing metabolic dysfunction in their teens and early 20s without realising it because standard health checks often don’t look deeply enough, or early enough.

A ‘normal’ HbA1c or fasting glucose test might reassure someone, while fasting insulin, HOMA-IR, or continuous glucose monitoring would reveal the beginnings of insulin resistance and blood sugar instability. These are the very tests that Dr Grosser uses to detect the early metabolic shifts that traditional care often misses.

The need for early intervention

By the time Type 2 diabetes is diagnosed in a 30-year-old, the underlying insulin resistance has often been in place for a decade or more. They are more likely to require insulin therapy, and more likely to develop other metabolic conditions like high blood pressure, fatty liver disease, and heart disease.

Early detection can help to reverse the process while it’s still possible.

Dr Grosser uses a combination of functional testing and advanced metabolic profiling to catch issues early. This could include fasting insulin and glucose testing, inflammatory markers, micronutrient status, hormone balance, and even mitochondrial function.

The aim isn’t just to treat high blood sugar, but to understand what’s driving it, whether that’s nutritional deficiencies, chronic stress, poor sleep, poor detoxification, or a combination of all of the above.

Prevention isn’t just about willpower

Metabolism is shaped by more than diet and exercise, it’s influenced by stress, trauma, hormonal balance, sleep quality, and environmental toxins. Dr Grosser equips patients with the data and support they need to truly change their health trajectory.

This often includes support from a nutritionist, personalised health coaching, resistance training plans, and guidance on supplementation. When necessary, short-term medication support, like low-dose GLP-1s such as Ozempic or Mounjaro, may be used as a kick-start, never a crutch.

Everything is built around the goal of restoring long-term metabolic health, not just treating symptoms.

Measuring the deeper impact with TruAge

For those concerned they’re at risk, TruAge biological testing offers a powerful window into how quickly the body is aging on the inside. Many people with early-onset diabetes show signs of accelerated biological aging, which may help explain why complications can appear so early.

With TruAge, Dr Grosser can not only track biological aging but also measure the success of intervention efforts over time.

With the right screening tools, early support, and a commitment to treating the root causes, it’s possible to prevent, reverse, and repair metabolic dysfunction, before it becomes a lifelong problem.

If you’re under 40 and concerned about blood sugar, insulin, or weight gain, now is the time to act. Book a consultation with Dr Grosser to explore your metabolic health and take proactive steps to protect your future.

/by

A Breakthrough Treatment for Adrenal-Based Hypertension

High blood pressure is one of the most common, and most dangerous, chronic conditions. For many, it becomes a lifelong diagnosis, managed with daily medication and routine check-ups.

Targeted Thermal Therapy (Triple T) is an emerging treatment that is gaining attention in the UK for its potential to cure a specific form of high blood pressure.

For patients with adrenal-based hypertension, this could represent a true breakthrough.

The role of the adrenal glands in hypertension

While most people associate high blood pressure with diet, stress, or genetics, there’s growing recognition of the role hormones play – particularly those produced by the adrenal glands. These small glands release a range of hormones that regulate stress responses, metabolism, and more.

In some patients, a condition known as primary aldosteronism causes the adrenals to overproduce aldosterone, a hormone that causes the body to retain sodium and water, thereby raising blood pressure.

This form of hypertension is difficult to control with standard medication. It often goes undiagnosed because it requires specific hormonal testing, not typically included in routine blood pressure tests.

What is Triple T?

Targeted Thermal Therapy is a minimally invasive procedure that uses heat to treat the tissue responsible for abnormal aldosterone production. Rather than removing the entire adrenal gland, Triple T selectively targets the dysfunctional area, leaving the rest of the gland intact.

The result is reduced aldosterone production, improved blood pressure control, and, in many cases, the ability to stop, or significantly reduce, medication.

According to early data from UK pilot studies, the treatment has shown high success rates, with some patients achieving full normalisation of blood pressure and hormone levels within weeks.

A Functional Medicine approach

Where conventional cardiology often stops at symptom control, functional medicine asks: why is this happening? What are the hormonal, inflammatory, or metabolic drivers that led to this diagnosis in the first place?

As a Functional Medicine Certified Practitioner and Interventional Cardiologist, Dr Konrad Grosser approaches stress-related health issues holistically applying a systems biology approach.

Targeted Thermal Therapy is still emerging, and long-term data is being collected, but the potential is undeniable. It aligns with everything Dr Grosser’s practice is built around: precise diagnosis, personalised treatment, and the pursuit of lasting, root-cause solutions.

If you’ve been diagnosed with high blood pressure, particularly if it’s difficult to control or you have a history of hormonal imbalance, this may be a sign of something deeper.

Book a consultation with Dr Grosser to explore the root cause of any imbalances, and for personalised treatment advice including stress management techniques or targeted therapies to support adrenal function.

/by

Rising Heatwaves and Impact on Aging Populations

Extreme heat is no longer a rare event. Across the UK and Europe, summer temperatures are rising, and heatwaves are becoming more frequent and intense. For healthy adults, this often means discomfort and disrupted routines. For older people, and those with chronic health conditions, heat stress can be far more serious and even life-threatening.

The human body is designed to regulate temperature through sweating, circulation, and changes in behaviour. However, with age and illness, these adaptive systems become less efficient. Cardiovascular disease, diabetes, kidney problems, and even the medications used to manage them can all reduce the body’s ability to cope with heat.

The result is a growing vulnerability in older populations, made more urgent by the pace of climate change.

Why older adults are at greater risk

Aging naturally brings changes in circulation, sweat gland function, and hydration balance. This means older adults are less able to release excess body heat and more likely to become dehydrated. Chronic conditions compound this risk. For example:

  • Cardiovascular disease limits the ability to adjust blood flow to the skin
  • Type 2 diabetes can cause nerve damage that impairs sweating and alters thirst perception
  • Kidney disease reduces fluid balance control, raising the risk of dehydration
  • Certain medications such as diuretics, beta-blockers, and anticholinergics interfere with cooling mechanisms

These overlapping risks help explain why hospital admissions and mortality rates spike during periods of extreme heat, particularly in older adults.

The broader impact of climate stress

Heat stress is not only an acute danger. Repeated exposure to high temperatures accelerates underlying biological aging. Oxidative stress, chronic inflammation, and strain on the cardiovascular and renal systems all contribute to faster cellular decline. In this way, climate stress adds to the burden of aging, one that traditional medical care is poorly equipped to address.

This is where functional medicine proves invaluable. Rather than treating heat-related illness once it arises, the goal is to build resilience in advance, strengthening the body’s ability to cope with environmental challenges.

Functional medicine and heat resilience

At Kent Cardio, Dr Konrad Grosser integrates functional medicine with advanced screening to help patients understand and improve their capacity to adapt to stressors like heatwaves. Tools such as TruAge testing provide insight into how the body is aging at a cellular level. Patients whose biological age is advancing more quickly than expected may be at greater risk of complications during heat events.

Detecting any issues early allows for interventions that improve overall health stability, making it easier for the body to withstand external stresses.

Practical strategies are then tailored to the individual. These may include:

  • Optimising hydration and electrolyte balance through diet and supplementation
  • Supporting cardiovascular function with targeted exercise and nutrition
  • Reducing systemic inflammation through personalised dietary changes
  • Adjusting medications where possible to reduce heat sensitivity
  • Strengthening sleep and stress management to stabilise the nervous system

Prevention as a long-term strategy

The rising frequency of heatwaves highlights the importance of prevention, not just treatment. Waiting until health problems emerge during a heat crisis is no longer sufficient. Instead, building resilience needs to become part of everyday healthcare for older adults and those with chronic disease.

By combining functional medicine, advanced screening, and personalised care, Dr Grosser’s approach allows patients to uncover vulnerabilities before they become critical. This proactive model does more than prepare individuals for the next hot summer. It creates a foundation of health that supports long-term independence and quality of life, even as environmental challenges grow.

Looking ahead

Climate change will continue to place pressure on aging populations. The choice is whether to respond reactively, dealing with emergencies as they occur, or proactively, by strengthening health at its foundations. Through tools like TruAge, and through lifestyle-focused functional medicine, patients at Kent Cardio can take meaningful steps to protect themselves.

Book a consultation with Dr Grosser today to learn more.

/by

Genetic Link Between Type 2 Diabetes and Cancer

Diabetes and cancer are often treated as two separate diseases, but new research suggests they are more connected than many realise. A recent large-scale genetic study has identified variants that raise the risk of both Type 2 diabetes and certain cancers, including breast, bowel, and pancreatic.

This discovery helps explain why people with diabetes are statistically more likely to develop cancer, and the importance of rethinking how we approach prevention.

Shared genetic pathways

For years, the link between Type 2 diabetes and cancer was largely attributed to lifestyle factors. Central obesity, high blood sugar, and chronic inflammation all create an environment in the body that promotes both metabolic disease and uncontrolled cell growth. While this remains true, the new findings show that genetics also play a significant role.

Some of the same genetic markers that influence how the body regulates glucose and insulin also affect how cells divide and repair. When these pathways are disrupted, the risk of both diabetes and certain cancers rises in parallel.

Diabetes is not just a metabolic disorder, and cancer is not just a genetic accident. They share deeper roots that must be addressed together.

Where conventional screening falls short

Standard screening tools are important, but they don’t always capture the full picture. HbA1c blood tests can detect diabetes once it has already developed, but they do not reveal the years of insulin resistance and metabolic stress that come beforehand. Likewise, cancer screening tests such as mammograms, PSA blood tests, or colonoscopies can only detect certain cancers, often at later stages.

Cancers like pancreatic, ovarian, and kidney currently have no routine screening pathways. Even where testing exists, false negatives and false positives remain a reality. This means many people at increased risk, including those with genetic predispositions, may go undetected until symptoms appear.

Functional medicine and advanced testing

At his private clinic, Dr Konrad Grosser takes a broader approach. By combining functional medicine with advanced personalised screening, he helps patients identify risks long before they become visible in standard tests.

Tools such as TruAge, which measures biological age and tracks how quickly the body is aging at a cellular level, and TruIntelli, a DNA/RNA-based multi-cancer screening test, are central to this approach. These technologies provide insight into both genetic predisposition and early biological changes, often years before symptoms arise.

Rather than treating conditions as isolated events, Dr Grosser uses these results to build a complete picture of a patient’s metabolic, genetic, and lifestyle profile. This allows for highly targeted prevention strategies, tailored to the individual.

Prevention through lifestyle and early intervention

Genetics may increase susceptibility, but they do not determine destiny. Functional medicine focuses on how lifestyle, environment, and medical support can influence gene expression and reduce disease risk.

For patients at higher risk of both diabetes and cancer, practical strategies include:

  • Reducing abdominal fat through tailored nutrition and exercise programmes
  • Stabilising blood sugar levels to limit the metabolic stress that drives both diabetes and cancer growth
  • Supporting the body’s natural repair systems with anti-inflammatory diets, stress reduction, and sleep optimisation
  • Using targeted therapies where appropriate to reset metabolic processes

Combined with advanced screening, these measures help patients take control of their health long before disease develops. Book a consultation with Dr Grosser today to find out more.

/by

Can Weight Loss Medications Help with Diabetes?

Managing Type 2 diabetes typically requires resetting the body’s deeply interconnected metabolic systems. For many people, the cycle of insulin resistance, central weight gain, and fluctuating blood sugar becomes a trap that diet and exercise alone can’t easily break. This is where medications like Ozempic (semaglutide) and Mounjaro (tirzepatide) can offer an important way forward.

Under the care of Dr Konrad Grosser, these medications are not seen as long-term solutions or one-size-fits-all prescriptions. Instead, they’re used as part of a targeted, medically supervised plan that focuses on early intervention, metabolic reset, and long-term lifestyle change.

The goal is not just to lower blood sugar or drop a few kilograms, but to reverse the underlying patterns that lead to chronic disease.

Understanding the role of GLP-1s

Both Ozempic and Mounjaro work by mimicking naturally occurring gut hormones called GLP-1, which influence insulin release, appetite, and the speed at which food leaves the stomach. Mounjaro goes a step further by also acting on GIP receptors, which appear to amplify these metabolic effects.

The result is a medication that can dramatically improve blood sugar control while also reducing appetite and promoting fat loss, particularly in those with central obesity and insulin resistance.

While the mechanisms are impressive, the true success lies in how these medications are used. The aim is not to stay on them forever, but to create a short, focused window (usually between six and twelve months), where the medication gives the body and brain the chance to reset.

The importance of a low-dose strategy

Rather than escalating to the maximum dose too quickly, Dr Grosser adopts a low-dose strategy from the start. This helps minimise unpleasant side effects and gives the body time to adapt. More importantly, it makes the transition off the medication smoother when the time comes, reducing the risk of rebound weight gain or metabolic instability.

This cautious approach is paired with ongoing clinical monitoring. Throughout the treatment period, patients are regularly assessed for thyroid and liver function, pancreatic enzymes, and kidney health.

By keeping a close eye on these markers, any emerging concerns can be addressed early, ensuring patient safety and maintaining the integrity of the broader treatment plan.

A total body approach

Weight loss drugs may be the entry point, but they are never the full solution. Dr Grosser’s approach is grounded in a broader strategy that addresses nutrition, exercise, hormone balance, and long-term metabolic health. Every patient receives tailored nutritional guidance, including a detailed assessment with a nutritionist. This is often combined with health coaching to support behaviour change, improve consistency, and tackle the lifestyle factors that underlie metabolic dysfunction.

Muscle preservation is also a key concern, especially during periods of weight loss. That’s why resistance training is encouraged from the outset, supported by a foundation of quality sleep, stress management, and targeted supplementation.

Many patients benefit from additional support such as multivitamins, omega-3 fatty acids, and increased protein intake, which help to preserve muscle mass and support cellular repair.

More sophisticated diabetes tracking

The benefits of GLP-1s go beyond what can be seen on the scales. Patients often experience improvements in insulin sensitivity, lower levels of inflammation, and better control of triglycerides and blood pressure. Fatty liver also called steatosis hepatis is a significant risk factor for liver cirrhosis and liver cancer and is something seen in many patients with diabetes or metabolic syndrome. With the right nutritional and medication strategy one would normally expect a full recovery of this dangerous condition within 6-12 months.

These changes are measurable and meaningful, and when combined with functional testing, they provide a detailed snapshot of progress.

By integrating fasting insulin, HOMA-IR, omega-3 status, nutritional markers, and TruAge biological age testing, Dr Grosser can track how each intervention is influencing your body at the cellular level. It’s a far more sophisticated view than standard diabetes management allows, and it puts patients firmly in control of their long-term health.

If you’ve struggled with weight, blood sugar, or insulin resistance, and feel stuck in a cycle that conventional approaches haven’t resolved, it may be time for a new direction. Book a consultation today.

/by

What Standard Health Checks Can Miss

We often take comfort in a clean bill of health, but do we truly understand what these standard tests are telling us? More importantly, what can standard health checks miss?

The reality is, conventional health screenings often miss the early warning signs of disease. They catch the crisis once it’s arrived, but overlook the subtle dysfunction that builds for years, sometimes decades, beneath the surface.

Dr Konrad Grosser’s integrative, functional medicine approach goes further, offering a more accurate view of your health trajectory by examining the deeper biochemical markers that truly matter.

When standard health checks miss hidden risks

Many standard blood tests are designed to flag full-blown disease. They detect diabetes when your blood sugar is already out of control. They highlight thyroid problems once symptoms are severe. They show liver dysfunction once damage is well underway. But what about the grey zone; the long lead-in where things are beginning to go wrong quietly?

How KentCardio applying functional medicine strategies goes beyond standard checks

At its core, functional medicine is about identifying the why behind your symptoms. It recognises that the body is an interconnected system, not a series of isolated organs, and that health is shaped by the interaction between your genes, environment, nutrition, and lifestyle.

So instead of waiting for red flags on a basic blood test, functional medicine looks at:

  • Biological age (how fast your cells are ageing, not just your chronological age)
  • Hormone balance (including early signs of thyroid dysfunction or adrenal fatigue)
  • Inflammatory markers (which often appear before any visible symptoms)
  • Immune regulation (to catch underlying autoimmunity or chronic infections)
  • Detoxification capacity (your body’s ability to clear toxins and environmental stressors)

When brought together, these markers tell a much more complete, and actionable, story.

One cohesive prevention strategy

Over the last few months, we’ve explored how factors like stress, air pollution, poor sleep, ultra processed foods, and metabolic imbalance can all contribute to accelerated biological aging. Often, these factors work in tandem, slowly undermining your health long before traditional screenings raise the alarm.

Take insulin resistance, for example. HbA1c may appear ‘normal’ for decades, while fasting insulin quietly climbs and inflammation creeps in. Or consider cognitive decline, which research shows can start with abnormal brain metabolism decades before symptoms. Standard checks won’t flag this, but TruAge testing will.

This is why Dr Grosser combines advanced biological age assessments (TruAge) with functional tests like fasting insulin, omega-3 index, homocysteine, nutrient panels, and mitochondrial function. It’s a multi-layered approach designed not just to detect disease, but to prevent it from developing in the first place.

Why functional medicine is the future

As a Functional Medicine Certified Practitioner and classically trained Interventional Cardiologist, Dr Grosser is uniquely positioned to combine the best of both worlds and only uses the best of evidence-based medicine like cardiac imaging, risk scoring, and acute care, while also integrating a personalised, systems-based approach to prevention and long-term health.

In a time when chronic illness is rising, it’s clear that reactive care isn’t enough. Prevention has to become the priority, and that means going beyond standard health screenings.

If you’ve ever felt that something is ‘off’ despite your GP saying everything looks normal, or if you’re simply ready to invest in a longer, healthier life, functional testing can reveal what standard checks overlook.

Book a consultation with Dr Grosser today to explore how TruAge and comprehensive functional testing can help you stay ahead of the curve and take control of your health before problems arise.

/by

Cognitive Decline Starts Decades Before Symptoms – Can You Afford to Wait?

Dementia and Alzheimer’s are cruel diseases, usually associated with older patients. However, cognitive decline is not a normal part of aging. The changes in brain metabolism, inflammation, and detox pathways, that can lead to cognitive decline, begin far earlier.

Those with familial Alzheimer’s disease show abnormal brain glucose metabolism up to 18 years before symptoms begin, and measurable brain atrophy 13 years before any clinical signs appear.

This article will explore how TruAge epigenetic markers, homocysteine, omega-3 index, and mitochondrial testing can detect cognitive decline risks.

What drives early cognitive decline?

At its core, cognitive decline is a metabolic issue. When your brain cells can’t produce or access enough energy, often due to insulin resistance, mitochondrial dysfunction, or poor nutrient status, they start to struggle. Over time, this leads to inflammation, impaired neurotransmitter production, and eventually, neurodegeneration.

Here are just a few of the factors that contribute:

  • High homocysteine – Elevated homocysteine levels are linked to increased risk of dementia and vascular damage. This amino acid becomes toxic in excess and is often a sign of B vitamin deficiency or poor methylation.
  • Low omega-3 index – DHA and EPA, found in fatty fish and high-quality supplements, are essential for brain structure and anti-inflammatory signalling. A low omega-3 index is a known risk factor for cognitive decline.
  • Mitochondrial dysfunction – Your brain consumes a disproportionate amount of your body’s energy. When mitochondria (the powerhouses of your cells) aren’t working well, neurons can’t function properly, and long-term damage follows.
  • Toxic burden – Impaired detox pathways can lead to a build-up of neurotoxic compounds, which further strain brain function and promote inflammation.

These imbalances often go unnoticed in standard blood work, but they can be picked up with functional testing long before symptoms emerge.

TruAge: Measuring the real risk

Rather than waiting for signs of decline to appear, TruAge measures epigenetic markers that reveal how fast you’re aging at a cellular level, including in your brain. If your biological age is outpacing your chronological one, it’s a sign that underlying stressors, e.g. inflammation or metabolic dysfunction, may already be at play.

TruAge doesn’t just give you a number. It offers a detailed insight into how lifestyle, environment, and genetics are shaping your future health, giving you time to intervene and change the trajectory if needed.

Alongside TruAge, Dr Grosser uses a targeted suite of functional tests to evaluate brain-related risks in more depth. These include tests for identifying methylation or B-vitamin issues, Omega-3 Index testing, mitochondrial health panels and nutritional assessments.

Together, these tools create a comprehensive map of your brain’s resilience and highlight areas where intervention could protect against decline.

A preventive, personalised approach

As the only Functional Medicine Certified Interventional Cardiologist in the UK and Europe, Dr Konrad Grosser combines advanced cardiovascular care with deep-rooted expertise in metabolic and neurological health. He understands that cognitive decline is rarely the result of a single issue, it’s the accumulation of small imbalances, lifestyle stressors, and genetic tendencies.

That’s why his approach focuses on early testing, personalised strategies, and root-cause resolution, long before the first symptom appears.

If you’re concerned about your cognitive health or simply want to stay sharp for the years ahead, now is the time to act. Book your TruAge cognitive health assessment with Dr Grosser today.

/by

The Metabolic Trap: How Diabetes and Obesity Quietly Accelerate Disease

We often think of diabetes and obesity as conditions that develop gradually, with visible warning signs along the way. But do we truly understand how quietly and powerfully they drive the progression of some of our most serious diseases, including heart disease, stroke, and cancer?

The truth is, by the time traditional markers like HbA1c indicate a problem, the damage may already be well underway. That’s why early metabolic testing is crucial – detecting these issues long before symptoms appear.

Insulin resistance, obesity, and blood sugar instability

At the heart of this metabolic trap is insulin resistance. This occurs when your cells stop responding properly to insulin, the hormone responsible for moving glucose out of the bloodstream and into your tissues. When that process breaks down, blood sugar starts to rise, quietly at first, often without noticeable symptoms.

The body compensates by pumping out more insulin, which can eventually lead to hyperinsulinemia, inflammation, and fat storage, especially around the abdomen (central obesity).

What many people don’t realise is that this pattern often begins years, even decades, before a diagnosis of Type 2 diabetes. During this time, that ongoing metabolic stress can already be increasing your risk of:

  • Cardiovascular disease
  • Stroke
  • Neurodegenerative disorders
  • Certain cancers (including breast, colon, and pancreatic cancer)

A UK Biobank study of over 163,000 participants followed for 11 years found that those with obesity, insulin resistance, and inflammation had an 88% higher risk of death and a 20% increased risk of cancer compared to those without these risk factors.

Why HbA1c isn’t enough

Most standard diabetes screenings rely heavily on HbA1c, a marker that reflects your average blood sugar over the past two to three months. While useful in later stages of disease, it often lags behind the real problem by years. By the time HbA1c is elevated, insulin resistance has likely been developing silently for a long time. In other words, it’s like spotting smoke long after the fire has already been burning.

This is why Dr Grosser prioritises fasting insulin and HOMA-IR testing instead. These markers detect insulin resistance much earlier, giving patients a window of opportunity to reverse the process before it leads to more serious health problems.

Functional testing for early insight

As well as fasting insulin and HOMA-IR (a calculation that reflects insulin sensitivity), Dr Grosser may recommend continuous glucose monitoring (CGM). CGM offers real-time insight into how your body responds to specific foods, stress, and sleep, allowing for highly personalised dietary and lifestyle adjustments.

Metabolic health can also be influenced by your body’s micronutrient status. Dr Grosser can assess levels of key nutrients that support metabolic processes, such as:

  • Magnesium (crucial for insulin sensitivity)
  • Vitamin D (linked to lower inflammation and better glucose control)
  • B vitamins (important for energy metabolism and methylation)
  • Omega-3s (anti-inflammatory)

Deficiencies in these areas often go undetected, yet they play a major role in the progression of chronic disease. By addressing them early, patients can improve their metabolic flexibility and overall resilience.

A holistic, preventative approach

Dr Konrad Grosser combines in-depth cardiovascular expertise with a functional, root-cause approach. By identifying early warning signs and understanding the full metabolic picture, he empowers patients to prevent disease, not just react to it.

The metabolic trap doesn’t have to define your future. With the right testing and guidance, it’s possible to escape it, often long before formal diagnoses appear.

Book a fasting insulin assessment with Dr Grosser today.

/by

DISCLAIMER PRIVACY POLICY